Mode
Text Size
Log in / Sign up
N/A N=331 Randomized Single-blind Treatment

A Study to Compare the NexGen LPS and LPS-Flex Knee Implants

Total Knee Arthroplasty · Osteoarthritis

Enrolled (actual)
331
Serious AEs
9.7%
Results posted
May 2012
Primary outcome: Primary: Postoperative Range of Motion (ROM) — 102.3; 106.8; 117.6; 118.2 degrees

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
NexGen LPS-Flex Fixed Bearing Knee (Device); NexGen Legacy Posterior Stabilized Knee (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Zimmer Biomet
Primary completion
Dec 2009

Outcome Measures

OutcomeResultp-value
PRIMARY
Postoperative Range of Motion (ROM)
102.3; 106.8; 117.6; 118.2; 120.3; 121.7
SECONDARY
Return to Function (RtF) Via Knee Society Score (Modified)
56.4; 58.5; 79.2; 79.7; 81.1; 81.7

Summary

The purpose of this study is to test for significant differences in functional outcomes obtained by using a NexGen LPS versus a NexGen LPS-Flex knee implant. Specifically, it is predicted that an increase in postoperative range of motion will be experienced by patients treated with the NexGen LPS-Flex knee implant.

Eligibility Criteria

Inclusion Criteria

  • Age, 21-80 years
  • Sex, Males and females will be included
  • BMI less than or equal to 39 and calf-thigh less than or equal to 90 degrees
  • Stable health, the patient would be able to undergo surgery and participate in the follow-up program based on physical examination and medical history.
  • Patient is willing and able to cooperate in follow-up therapy.
  • Patient exhibits preoperative radiographic evidence of joint degeneration consistent with TKA that cannot be treated in non-operative fashion.
  • Patient has stable and functional collateral ligaments.
  • Patient has potential to perform higher than average range of motion activities.
  • Operative side range of motion flexion greater than or equal to 90 degrees.
  • Severe knee pain and disability due to degenerative joint disease.
  • Patient or patient's legal representative has signed the Informed Consent form.

Exclusion Criteria

  • Previous history of infection in the affected joint.
  • Previously failed knee endoprosthesis of any kind.
  • Charcot joint disease or other severe neurosensory deficits.
  • Previous patellectomy.
  • Patient is skeletally immature.
  • Grossly insufficient femoral or tibial bone stock.
  • Patient is pregnant.
  • Varus or valgus deformity greater than 20 degrees.
  • Fixed flexion deformity greater than 15 degrees.
  • Previous high tibial osteotomy.
  • Previous femoral osteotomy.
  • Patient is a poor compliance risk - currently treated for ethanol or drug abuse, physical or mental handicap, etc.
  • Loss of musculature or absence of musculoligamentous supporting structures required for adequate soft tissue balance.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00763386). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search